首页> 外文OA文献 >Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy

【2h】

Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy

机译：将Biscuth-213与纳米展开结合起来：寻找目标α治疗的完美匹配

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Yana Dekempeneer; Vicky Caveliers; Matthias D’huyvetter; Dominic Maertens; Mireille Gysemans; Maarten Oom; Tony Lahoutte; Catarina Xavier; Frank Bruchertseifer; Alfred Morgenstern; Thomas Cardinaels;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle [J] . Dekempeneer Yana, Keyaerts Marleen, Krasniqi Ahmet, Expert opinion on biological therapy . 2016,第8期

机译：使用短寿命α粒子的靶向α疗法以及纳米抗体有望作为靶向载体
2. The Evolving Clinical Role of Actinium-225 and Bismuth-213 for Targeted Alpha Therapy (TAT) - Production, Radiopharmaceutical Development and Clinical Applications [J] . Valery Radchenko, Paul Schaffer, F.F. (Russ) Knapp Current radiopharmaceuticals . 2018,第3期

机译：Actinium-225和Biscuth-213对靶向α治疗（TAT） - 生产，放射性药物开发和临床应用的不断发展的临床作用
3. Finding the Perfect Match: A Combined Computational and Experimental Study toward Efficient and Scalable Photosensitized [2+2] Cycloadditions in Flow [J] . Williams Jason D., Nakano Momoe, Gerardy Romaric, Organic process research & development . 2019,第1期

机译：寻找完美的匹配：对流动中有效和可扩展的光敏和可缩放的光敏[2 + 2]环加成的组合计算和实验研究
4. Production of Carrier Free Actinium-225/ Bismuth-213 and the Application Possibilities for Alpha-Immunotherapy [C] . C. Apostolidis, F. Bruchertseifer, A. Morgenstern International Conference on Isotopes (5ICI) . 2005

机译：生产载体免疫actinium-225 /铋-213以及α免疫疗法的应用可能性
5. Finding the Perfect Match: Dimension Analysis and Development of the External Sponsorship Congruence Scale [D] . ?Evans, Kelly 2019

机译：寻找完美匹配：尺寸分析和外部赞助同一年规模的发展
6. Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle [O] . Yana Dekempeneer, Marleen Keyaerts, Ahmet Krasniqi, -1

机译：使用短寿命α粒子的靶向alpha治疗以及纳米抗体有望作为靶向载体
7. Targeted-Alpha-Therapy Combining Astatine-211 and anti-CD138 Antibody in a Preclinical Syngeneic Mouse Model of Multiple Myeloma Minimal Residual Disease [O] . Sébastien Gouard, Catherine Maurel, Séverine Marionneau-Lambot, 2020

机译：靶向α-治疗组合astatine-211和抗CD138抗体在多发性骨髓瘤的临床前同源小鼠模型中的临床前同源疾病
8. Targeted Delivery of Alpha Particle-Emitting Radionuclides and Their Alpha-Emitting Progeny: Breast Cancer Therapy Using Lipsome Encapsulated Alpha Emitters. [R] . Sgouros, G. 2001

机译：靶向递送α粒子发射放射性核素及其α-发射子代：使用Lipsome封装的alpha发射体进行乳腺癌治疗。

Combining Bismuth-213 with Nanobodies: Finding the Perfect Match for Targeted Alpha Therapy

著录项

引文网络

相似文献

相关主题

期刊订阅